Literature DB >> 103618

Relationship of molecular weight to antiviral and antitumor activities and toxic effects of maleic anhydride-divinyl ether (MVE) polyanions.

P S Morahan, D W Barnes, A E Munson.   

Abstract

The molecular weight (MW) and dose dependency of several of the toxic effects and antitumor and antiviral activities of a new series of five maleic anhydride-divinyl ether copolymers (MVE) were established. Each polyanion preparation was relatively homogeneous and exhibited a narrow MW range, from 12,500 (MVE-1) to greater than 52,000 (MVE-5). All of the polyanions were effective as adjuvants to surgery against the metastatic Lewis lung carcinoma, and also exhibited marked antitumor activity against the P815 mastocytoma. MVE-1 retained antitumor activity while losing considerable antiviral activity. This polyanion also exhibited the least toxicity with regard to criteria such as sensitization to the lethal effects of endotoxin, inhibition of reticuloendothelial function, and depression of the microsomal mixed functional oxidase system. The MVE-4 (MW, 32,000) and MVE-5 (MW, 52,600) polyanions exhibited potent antitumor and antiviral activity, but also demonstrated dose-dependent toxic effects.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 103618

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  6 in total

1.  Phase I study of MVE-2 evaluating toxicity and biologic response modification capability.

Authors:  J D Hainsworth; J T Forbes; W W Grosh; F A Greco
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

2.  Phase II trial of MVE-II in metastatic malignant melanoma.

Authors:  J Rinehart; J LaForge; D Gochnour; J Neidhart
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

3.  Resistance to infections in mice with defects in the activities of mononuclear phagocytes and natural killer cells: effects of immunomodulators in beige mice and 89Sr-treated mice.

Authors:  P S Morahan; P H Coleman; S S Morse; A Volkman
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

4.  Antimicrobial activity of various immunomodulators: independence from normal levels of circulating monocytes and natural killer cells.

Authors:  P S Morahan; W L Dempsey; A Volkman; J Connor
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

5.  Clinical pharmacology of the biological response modifier maleic anhydride divinyl ether copolymer (MVE-2).

Authors:  M G Rosenblum; A M Rios; E M Hersh
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

6.  Application of tumor, bacterial and parasite susceptibility assays to study immune alterations induced by environmental chemicals.

Authors:  J H Dean; M I Luster; G A Boorman; R W Leubke; L D Lauer
Journal:  Environ Health Perspect       Date:  1982-02       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.